CN101432279A - 吡啶基甲基哌嗪和吡啶基甲基哌啶衍生物的n-氧化物 - Google Patents

吡啶基甲基哌嗪和吡啶基甲基哌啶衍生物的n-氧化物 Download PDF

Info

Publication number
CN101432279A
CN101432279A CNA2007800157788A CN200780015778A CN101432279A CN 101432279 A CN101432279 A CN 101432279A CN A2007800157788 A CNA2007800157788 A CN A2007800157788A CN 200780015778 A CN200780015778 A CN 200780015778A CN 101432279 A CN101432279 A CN 101432279A
Authority
CN
China
Prior art keywords
compound
nitrogen atom
oxides
fluorophenyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800157788A
Other languages
English (en)
Chinese (zh)
Inventor
M·P·M·范艾尔
P·H·范埃姆斯特达姆
G·A·巴福
J·A·巴克尔
C·丹柏司腾
A·H·J·赫尔曼斯
J·卓格达格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37198739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101432279(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of CN101432279A publication Critical patent/CN101432279A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2007800157788A 2006-05-02 2007-04-25 吡啶基甲基哌嗪和吡啶基甲基哌啶衍生物的n-氧化物 Pending CN101432279A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06113393 2006-05-02
US60/796,551 2006-05-02
EP06113393.0 2006-05-02

Publications (1)

Publication Number Publication Date
CN101432279A true CN101432279A (zh) 2009-05-13

Family

ID=37198739

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800157788A Pending CN101432279A (zh) 2006-05-02 2007-04-25 吡啶基甲基哌嗪和吡啶基甲基哌啶衍生物的n-氧化物

Country Status (16)

Country Link
EP (1) EP2024363B1 (enExample)
JP (1) JP2009535374A (enExample)
CN (1) CN101432279A (enExample)
AR (1) AR060832A1 (enExample)
AU (1) AU2007247251B2 (enExample)
BR (1) BRPI0710792A2 (enExample)
CA (1) CA2649479A1 (enExample)
CL (1) CL2007001245A1 (enExample)
EA (1) EA200870492A1 (enExample)
MX (1) MX2008013887A (enExample)
PE (1) PE20080064A1 (enExample)
SA (1) SA07280218B1 (enExample)
TW (1) TW200811150A (enExample)
UA (1) UA96756C2 (enExample)
WO (1) WO2007128694A1 (enExample)
ZA (1) ZA200809112B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101711236B (zh) * 2007-04-12 2012-10-31 Nsab神经研究瑞典公司分公司 表现出改善的心血管副作用特性的多巴胺受体稳定剂/调节剂的n-氧化物和/或二-n-氧化物衍生物
MX347209B (es) 2011-12-08 2017-04-19 Teva Pharmaceuticals Int Gmbh La sal de bromhidrato de pridopidina.
AU2013243461A1 (en) 2012-04-04 2014-11-06 Teva Pharmaceuticals International Gmbh Pharmaceutical compositions for combination therapy
GB201801128D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
TW530054B (en) 1997-09-24 2003-05-01 Duphar Int Res New piperazine and piperidine compounds

Also Published As

Publication number Publication date
JP2009535374A (ja) 2009-10-01
UA96756C2 (en) 2011-12-12
AR060832A1 (es) 2008-07-16
CA2649479A1 (en) 2007-11-15
MX2008013887A (es) 2009-01-29
AU2007247251A1 (en) 2007-11-15
TW200811150A (en) 2008-03-01
BRPI0710792A2 (pt) 2011-06-21
EP2024363B1 (en) 2012-08-01
EA200870492A1 (ru) 2009-04-28
ZA200809112B (en) 2009-07-29
WO2007128694A1 (en) 2007-11-15
CL2007001245A1 (es) 2008-05-30
AU2007247251B2 (en) 2011-11-03
SA07280218B1 (ar) 2010-10-03
EP2024363A1 (en) 2009-02-18
PE20080064A1 (es) 2008-03-19

Similar Documents

Publication Publication Date Title
US6395742B1 (en) 2,4-diaminopyrimidine derivatives
CN102918031A (zh) 放射标记的化合物及其方法
NO310070B1 (no) Benzo[g]kinolinderivater, fremstilling herav, farmasöytiske midler og preparater inneholdende disse samt anvendelse av derivatene for fremstilling av medikamenter
TWI634117B (zh) 嗎啉衍生物
JP2008519083A (ja) アミノキナゾリン化合物
CN100378109C (zh) 具有5-羟色胺受体亲和性的四环3-取代的吲哚类化合物
de la Fuente Revenga et al. Psychedelic-like properties of quipazine and its structural analogues in mice
CN1007352B (zh) 新的4h-1-苯并吡喃-4-酮的生产方法
DK171133B1 (da) 1-Pyridyl- eller -pyrimidyl-4-substitueret alkyl-piperaziner eller -homopiperaziner, fremstilling af disse, samt farmaceutiske præparater indeholdende disse
Giorgioni et al. Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
EP2619187B1 (en) Compounds and pharmaceutical compositions for treating disorders associated with the 5-ht1a and 5-ht2a receptors
JP3520177B2 (ja) セロトニン５−ｈｔ３受容体部分活性薬
AU2007247251B2 (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
JPH037257A (ja) ピリジン誘導体及びそれを有効成分とする向精神剤
CN101535258A (zh) 5ht2a和d3受体的醚衍生物双重调节剂
JP2009504799A (ja) ピペラジンおよびピペリジン誘導体のプロドラッグとしてのｎ−オキシド
JPH08283219A (ja) アラルキルアミノアルキルアミド誘導体
US6187769B1 (en) Benzoxazepine derivatives and their salts and medicaments containing the same
Quaglia et al. α2C-adrenoceptor modulators: a patent review
US20070275977A1 (en) N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
JPH07509711A (ja) 新規なピリジル−およびピリミジルピペラジン誘導体
KR20110074574A (ko) 1-부틸-2-히드록시아르알킬 피페라진 유도체 및 항-우울증제로서의 그 용도
JP2001515517A (ja) ７−〔（ピペリジン−１−イル）−プロポキシ〕−クロメン−４−オン誘導体、それらの製造およびそれらの医薬としての使用
HK1130474A (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
CN103130745B (zh) 二芳基哌嗪类化合物及其医药用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1130474

Country of ref document: HK

AD01 Patent right deemed abandoned

Effective date of abandoning: 20090513

C20 Patent right or utility model deemed to be abandoned or is abandoned
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1130474

Country of ref document: HK